News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Enzo Biochem Appoints Gary C. Cupit, Former Novartis Pharmaceuticals Corporation Executive, President Of Enzo Biochem Therapeutics Unit
October 16, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) today announced the appointment of Gary C. Cupit, PharmD, to the newly created position of President of Enzo Therapeutics, Inc.
Twitter
LinkedIn
Facebook
Email
Print
People
Novartis
MORE ON THIS TOPIC
FDA
After ‘most damaging period in FDA history,’ Makary will be hard to replace
May 13, 2026
·
3 min read
·
Tristan Manalac
Layoff Tracker
BioMarin trims Amicus headcount after acquisition
May 13, 2026
·
51 min read
·
BioSpace Editorial Staff
Venture capital
AI-fueled Isomorphic bags $2.1B, the second largest biotech round ever
May 13, 2026
·
2 min read
·
Tristan Manalac
FDA
FDA’s Makary to resign after Secretary Kennedy signs off
May 12, 2026
·
4 min read
·
Annalee Armstrong